Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Submitted by
admin
on April 3, 2012 - 10:12am
Source:
Yahoo/Fly on the Wall
News Tags:
ONYX Pharmaceuticals
regorafenib
GIST
Bayer
Headline:
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Do Not Allow Advertisers to Use My Personal information
